首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine
【2h】

Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine

机译:血管对认知障碍和中医治疗的贡献

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prevalence of cognitive impairment and dementia caused by cerebrovascular disease is likely to increase with the global aging population. Vascular contributions to cognitive impairment and dementia (VCID) is a wide spectrum term used to include a diverse heterogeneous group of cognitive syndromes with vascular factors regardless of the cause of pathogenesis. VCID ranges from mild cognitive impairment to full-blown dementia with vascular dementia (VaD) as the most severe stage. It is further complexed by the coexistence of other forms of dementia such as Alzheimer's disease (AD). Recent researches in the functions of the neurovascular unit (NVU) suggest that dysfunction of the NVU might be the cause of primary vascular events in the brain that leads to further neurodegeneration. In this review, we have briefly summarized various forms of VCID. There is currently no standard therapy for VCID or dementia. Given the fact that Traditional Chinese Medicine (TCM) has gained popularity worldwide, we also reviewed recent scientific and clinical findings on various antidementia TCM for the treatment of VCID, including Salvia miltiorrhiza, Huperzia serrata, Ligusticum chuanxiong, Ginkgo biloba, Panax ginseng, and also TCM formula Sailuotong capsule (SLT) and Fufangdanshen tablets (FFDS).
机译:随着全球人口老龄化,由脑血管疾病引起的认知障碍和痴呆的患病率可能会增加。血管对认知障碍和痴呆的贡献(VCID)是一个广谱术语,用于包括多种多样的异类认知综合征和血管因子,无论其病因是什么。 VCID的范围从轻度认知障碍到完全性痴呆,其中血管性痴呆(VaD)是最严重的阶段。其他形式的痴呆症(例如阿尔茨海默氏病(AD))并存,使情况进一步复杂化。对神经血管单位(NVU)功能的最新研究表明,NVU功能障碍可能是大脑中主要血管事件的原因,导致进一步的神经变性。在本文中,我们简要总结了各种形式的VCID。当前没有针对VCID或痴呆症的标准疗法。鉴于中药(TCM)已在世界范围内普及,我们还回顾了用于治疗VCID的各种抗痴呆中药的最新科学和临床发现,包括丹参,石杉石楠,川Li,银杏,人参和还有中药配方塞洛通胶囊(SLT)和复方丹参片(FFDS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号